The Scientist

» Week in Review and disease/medicine

Most Recent

image: Quick and Cheap Zika Detection

Quick and Cheap Zika Detection

By | May 3, 2017

A heat block, a truck battery, and a novel RNA amplification assay make for in-the-field surveillance of the virus.

0 Comments

image: Week in Review: April 24–28

Week in Review: April 24–28

By | April 28, 2017

Where Zika virus persists in monkeys; more-advanced mini brains; artificial womb supports fetal lambs for weeks; cancer mutations in stem cell lines; science marches around the globe

0 Comments

Studies of infected rhesus monkeys reveal the virus’s long-term hiding places in the body.

1 Comment

image: Week in Review: April 10–14

Week in Review: April 10–14

By | April 14, 2017

CRISPR patent ruling appealed; CRISPR-based nucleic acid test; an experimental gene therapy for Duchenne muscular dystrophy and a cell-based protocol for Parkinson’s disease show promise in mice

0 Comments

image: Week in Review: April 3–7

Week in Review: April 3–7

By | April 7, 2017

Virus triggers gluten intolerance in mice; UK bank offers clinic-ready hESC lines; researchers debate giant virus origins; cephalopods edit RNA; scientists screen noncoding genome with CRISPR

0 Comments

image: Contributors

Contributors

By | April 1, 2017

Meet some of the people featured in the April 2017 issue of The Scientist.

0 Comments

image: Hitting It Out of the Park

Hitting It Out of the Park

By | April 1, 2017

Cancer can be as evasive and slippery as a spitball, but new immunotherapies are starting to connect.

0 Comments

image: Location, Location, Location

Location, Location, Location

By | April 1, 2017

Since first proposing that a cell’s function and biology depend on its surroundings, Mina Bissell continues to probe the role of the extracellular matrix.

2 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.

0 Comments

Popular Now

  1. A Coral to Outlast Climate Change
  2. Antarctica Is Turning Green
  3. How to Tell a Person’s “Brain Age”
  4. Life Science Funding Cuts Leaked
    The Nutshell Life Science Funding Cuts Leaked

    According to a document posted online less than a day before the release of the official 2018 budget proposal, the National Institutes of Health could face even deeper cuts than previously suggested by the Trump administration.

AAAS